| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/03/2011 | US20110053973 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053962 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| 03/03/2011 | US20110053961 Substituted xanthine derivatives |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury |
| 03/03/2011 | US20110053950 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053949 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 |
| 03/03/2011 | US20110053940 3,4-substituted piperidine derivatives as renin inhibitors |
| 03/03/2011 | US20110053935 Fused pyridines active as inhibitors of c-met |
| 03/03/2011 | US20110053924 Substituted piperidines as renin inhibitors |
| 03/03/2011 | US20110053911 Tricyclic derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 03/03/2011 | US20110053905 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110052695 Drug delivery platforms comprising silk fibroin hydrogels and uses thereof |
| 03/03/2011 | US20110052674 Angiotensin ii receptor blocker derivatives |
| 03/03/2011 | US20110052602 Diagnosis and Treatment of Age Related Macular Degeneration |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | CA2790390A1 Novel tetrahydroisoquinoline compounds |
| 03/03/2011 | CA2772094A1 Methods and compositions for preventing or treating ophthalmic conditions |
| 03/03/2011 | CA2771807A1 Treatment of macular degeneration |
| 03/02/2011 | EP2290079A2 Neurotrophic factors |
| 03/02/2011 | EP2289488A2 Remedies for diseases to be applied to eye |
| 03/02/2011 | EP2288600A1 Substituted arylcyclopentenes as prostaglandin ep2 agonists |
| 03/02/2011 | EP2288598A1 Thiophene derivatives useful as ocular hypotensive agents |
| 03/02/2011 | EP2288385A2 Combination therapy for glaucoma |
| 03/02/2011 | EP2288258A1 Inhibition of neovascularization by cerium oxide nanoparticles |
| 03/02/2011 | EP1884236B1 Angiogenesis inhibitor containing amine derivative as active ingredient |
| 03/02/2011 | EP1814848B9 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 03/02/2011 | CN101982184A Preparation method of taraxacum extract |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897617 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/01/2011 | US7897594 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 03/01/2011 | US7897157 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 03/01/2011 | CA2396590C 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021645A1 Bicyclic urea derivative or pharmacologically permitted salt thereof |
| 02/24/2011 | WO2011021594A1 Sustained drug delivery system |
| 02/24/2011 | WO2011021203A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | WO2011020193A1 Renin inhibitors |
| 02/24/2011 | WO2010136492A3 Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye. |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046546 Methods for treating headaches |
| 02/24/2011 | US20110046237 Compounds with activity at estrogen receptors |
| 02/24/2011 | US20110046235 Products comprising, and uses of, decarboxylated phenolic acids derived from chlorogenic acids of coffee |
| 02/24/2011 | US20110046215 Abnormal intraocular pressure treatment |
| 02/24/2011 | US20110046207 C5a binding nucleic acids |
| 02/24/2011 | US20110046198 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 02/24/2011 | US20110046177 Therapeutic quinoline and naphthalene derivatives |
| 02/24/2011 | US20110046170 Novel pyrimidine-pyridine derivatives |
| 02/24/2011 | US20110046158 Capped pyrazinoylguanidine sodium channel blockers |
| 02/24/2011 | US20110046156 Treatment of hearing and balance impairments with redox-active therapeutics |
| 02/24/2011 | US20110046136 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associcated therewith |
| 02/24/2011 | US20110046129 2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046087 Pharmaceutical composition, methods for treating and uses thereof |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110045091 Anti-angiogenesis, anticancer proliferation properties of lymphocytic-derived microparticles |
| 02/24/2011 | US20110045035 Methods of treating ophthalmic disorders |
| 02/24/2011 | US20110044970 Pharmaceutical compositions and methods for the treatment of dry eye |
| 02/24/2011 | US20110044957 Methods and systems for extended in vitro culture of neuronal cells |
| 02/24/2011 | US20110044908 Methods and Compositions for Treating and Identifying Compounds to Treat Age-Related Macular Degeneration |
| 02/24/2011 | US20110044904 Crystal forms of 2--adenosine |
| 02/24/2011 | CA2771257A1 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287183A1 Mutants PF4 polypeptides exhibiting an increased anti-angiogenic activity |
| 02/23/2011 | EP2286824A1 Non-covalent crosslinking agent for collagen |
| 02/23/2011 | EP2286799A2 Microspheres for active embolization |
| 02/23/2011 | EP2285796A1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 02/23/2011 | EP2285790A1 Therapeutic compounds |
| 02/23/2011 | EP2285378A1 Treatment for ocular-related disorders |
| 02/23/2011 | EP2285372A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/23/2011 | EP2285369A2 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases |
| 02/23/2011 | EP2285364A2 Therapeutic replenishment and enrichment of ocular surface lubrication |
| 02/23/2011 | EP2285346A1 Methods for improving lid margin and tear film function and treatment of lid margin desease using tetracycline family antibiotics |
| 02/23/2011 | EP2197456B1 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid |
| 02/23/2011 | EP1677774B1 Citicoline-based composition in combination with vitamins for the prevention and treatment of eye pathologies |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1144459B2 Cross-linked hyaluronic acids and medical uses thereof |
| 02/23/2011 | CN101981026A Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 02/23/2011 | CN101981012A Novel tetrahydroisoquinoline derivative |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979040A Medicament for treating central serous chorioretinopathy |
| 02/23/2011 | CN101979037A Medicament for treating diabetic complications and preparation method thereof |
| 02/23/2011 | CN101978975A Haematococcus extract preparation, and preparation method and use thereof |
| 02/23/2011 | CN101978968A Medicament for treating tympanitis |
| 02/23/2011 | CN101978951A 9,10-diphenylanthracene(DPA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 02/23/2011 | CN101618162B Traditional Chinese medicine for treating viral keratitis |
| 02/23/2011 | CN101220092B Human keratinized cell growth factor-1 analogue preparation method and application thereof |
| 02/22/2011 | US7894769 Wireless microphone communication system |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893068 Physiologically active substances |
| 02/22/2011 | US7892574 Topical administration of oxazolidinones for transdermal delivery |
| 02/22/2011 | CA2551409C Prostaglandin nitrooxyderivatives |
| 02/22/2011 | CA2486378C Preparation and application of total salvianolic acid |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |